Inc to "neutral" from "overweight" on Wednesday, citing concerns over waning growth prospects as subscription revenue and ...

U.S. Treasury yields are inching higher after Monday’s drop, as investors navigate the holiday-shortened trading week. But ...

In a report released today, Thomas Champion from Piper Sandler maintained a Buy rating on Amazon (AMZN – Research Report), with a price target ...

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for broad populations of cancer patients, today announced ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.41% of ...

On Tuesday, Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $14.38 which represents a slight increase of $1.12 or 8.45% from the prior close of $13.26. The stock opened at $13.

The Vegetarian Butcher plant-based meat brand has reportedly been put up for sale by Unilever boss Hein Schumacher.

Piper Sandler analyst Brent Bracelin raised the firm’s price target on Procore (PCOR) to $90 from $70 and keeps an Overweight ...

Piper Sandler believes that the overall uptrend in markets remains intact, adding that traders and investors should look to buy the dip on pullbacks. Read more here.

today announced that management will participate in a fireside chat at the Piper Sandler 36 th Annual Healthcare Conference on Thursday, December 5, 2024, at 9:00 AM Eastern Time. A live audio webcast ...

Inozyme Pharma is a pioneering clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for rare diseases that affect bone health and blood vessel function. We are ...

NEWTON, Mass., Nov. 25, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the ...